Rankings
▼
Calendar
NAGE FY 2021 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$423M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$67M
+13.8% YoY
Gross Profit
$41M
61.5% margin
Operating Income
-$27M
-40.1% margin
Net Income
-$27M
-40.2% margin
EPS (Diluted)
$-0.40
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$25M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$58M
Total Liabilities
$26M
Stockholders' Equity
$32M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$67M
$59M
+13.8%
Gross Profit
$41M
$35M
+17.6%
Operating Income
-$27M
-$20M
-36.4%
Net Income
-$27M
-$20M
-36.2%
← Q4 2020
All Quarters
Q1 2021 →